Systems and methods of neuromodulation stimulation for the restoration of sexual function

• US 20080071321A1
• Filed: 08/09/2007
• Published: 03/20/2008
• Est. Priority Date: 06/10/2004
• Status: Abandoned Application

• Current Assignee: Medtronic Urinary Solutions, Inc. (Medtronic Plc)
• Original Assignee: NDI Medical, Inc. (Medtronic Plc)
• Inventors: Boggs, Joseph, Thrope, Geoffrey, Strother, Robert, Mrva, Joseph
• Application Number:
  US11/891,214
• Publication Number:
  US 20080071321A1
• Time in Patent Office: Days
• US Class Current: 607/39
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/0512 Anal electrodes
• CPC Class Codes: A61N 1/0524 Vaginal electrodes
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control

Abstract

Systems and methods use an external and/or implantable pulse generator system for neuromodulation stimulation to treat sexual dysfunction by the unilateral or bilateral stimulation of a target nerve A and/or a target nerve B using one or more leads and electrodes implanted in tissue in the pelvic region. The electrical stimulation waveform may be conveyed to the target nerve A electrode for a first predetermined amount of time, and conveyed to the target nerve B electrode for a second predetermined amount of time.

Claims

1. A stimulation system for the treatment of sexual dysfunction comprising:

at least one elongated target nerve A lead sized and configured to be coupled to a pulse generator and implanted in tissue, the target nerve A lead including at least one target nerve A stimulation electrode sized and configured to be implanted in a tissue region at or near a target nerve A,

at least one elongated target nerve B lead sized and configured to be coupled to a pulse generator and implanted in tissue, the target nerve B lead including at least one target nerve B stimulation electrode sized and configured to be implanted in a tissue region at or near a target nerve B, and

at least one pulse generator to convey electrical stimulation waveforms to each of the target nerve A stimulation electrode and target nerve B stimulation electrode to stimulate the target nerve A and the target nerve B to treat sexual dysfunction.

2. A system according to claim 1:

wherein the pulse generator is an implantable pulse generator.

3. A system according to claim 1:

wherein the pulse generator is an external pulse generator.

4. A system according to claim 1:

wherein the target nerve A and the target nerve B are efferent nerves.

5. A system according to claim 1:

wherein the target nerve A is selected from the group consisting of the cavernous nerve and/or spinal, sacral, lumbar, and/or thoracic roots and/or branches;

the prostatic plexus and/or its spinal, sacral, lumbar, and/or thoracic roots and/or branches;

the pelvic nerve and/or its spinal, sacral, lumbar, and/or thoracic roots and/or branches;

the hypogastric nerve and/or its spinal, sacral, lumbar, and/or thoracic roots and/or branches; and

the splanchnic nerve and/or its spinal, sacral, lumbar, and/or thoracic roots and/or branches, and

wherein the target nerve B is selected from the group consisting of the pudendal nerve and/or its spinal, sacral, lumbar, and/or thoracic roots and/or branches;

the perineal nerve and/or its spinal, sacral, lumbar, and/or thoracic roots and/or branches;

the nerves that innervate the ischiocavernosus, bulbocavernosus, and/or bulbospongiosus muscles and/or their spinal, sacral, lumbar, and/or thoracic roots and/or branches; and

the nerves that innervate the transverse perineal muscles and/or their spinal, sacral, lumbar, and/or thoracic roots and/or branches.

6. A system according to claim 1:

wherein the electrical stimulation waveform is conveyed to the target nerve A electrode for a first predetermined amount of time, and then the stimulation waveform is conveyed to both the target nerve A electrode and the target nerve B electrode for a second predetermined amount of time.

7. A system according to claim 1:

wherein the electrical stimulation waveform is conveyed to the target nerve A electrode for a first predetermined amount of time, and then the stimulation waveform is conveyed to both the target nerve A electrode and the target nerve B electrode for a second predetermined amount of time, and then the stimulation waveform is conveyed only to the target nerve A electrode for a third predetermined amount of time.

8. A system according to claim 1:

wherein the electrical stimulation waveform is conveyed to the target nerve A electrode for a first predetermined amount of time, and then the stimulation waveform is conveyed to both the target nerve A electrode and the target nerve B electrode for a second predetermined amount of time, and then the stimulation waveform is conveyed only to the target nerve B electrode for a third predetermined amount of time.

9. A system according to claim 1:

wherein the electrical stimulation waveform comprises one or more variable stimulus parameters to improve and/or optimize the desired response, the variable stimulus parameters selected from the group consisting of a variable frequency component;

a variable duty cycle component;

a variable amplitude component;

a variable pulse width component;

a variable pulse shape component;

variable pulse phase component;

a variable stimulus on time component;

a variable stimulus off time component;

a variable ramp up component;

a variable ramp down component;

a variable amplitude modulation component;

a variable frequency modulation component;

a variable pulse modulation component;

a variable sequence component; and

a variable delay component.

10. A system according to claim 1:

wherein the electrical stimulation waveform conveyed to the target nerve A electrode comprises one or more waveform parameters that are different than the electrical stimulation waveform conveyed to the target nerve B electrode.

11. A system according to claim 10:

wherein the electrical stimulation waveform parameters are selected from the group consisting of amplitude;

frequency;

pulse width;

pulse shape;

pulse phase;

stimulus on time;

stimulus off time;

ramp up;

ramp down;

amplitude modulation;

frequency modulation;

pulse modulation;

variability; and

delay.

12. A system according to claim 1:

wherein at least one of the target nerve A electrode and the target nerve B electrode is introduced to at least one of the target nerve A and the target nerve B via the perineum in males and/or females for the restoration of sexual function.

13. A system according to claim 1:

wherein at least one of the target nerve A electrode and the target nerve B electrode is introduced to at least one of the target nerve A and the target nerve B via the anterior and/or posterior side of the pelvis in males and/or females for the restoration of sexual function.

14. A system according to claim 1:

wherein the electrical stimulation conveyed to at least one of the target nerve A electrode and the target nerve B electrode affect efferent stimulation of at least one of the target nerve A and the target nerve B, to produce an erection.

15. A system according to claim 1:

wherein the electrical stimulation conveyed to at least one of the target nerve A electrode and the target nerve B electrode affect afferent stimulation of at least one of the target nerve A and the target nerve B, the afferent stimulation activating central nervous system circuitry that coordinates and/or produces efferent activity in the at least one of the target nerve A and the target nerve B, to produce an erection.

16. A method of treating sexual dysfunction comprising:

providing at least one elongated target nerve A lead sized and configured to be coupled to a pulse generator and implanted in tissue, the target nerve A lead including at least one target nerve A stimulation electrode sized and configured to be implanted in a tissue region at or near a target nerve A,

providing at least one elongated target nerve B lead sized and configured to be coupled to a pulse generator and implanted in tissue, the target nerve B lead including at least one target nerve B stimulation electrode sized and configured to be implanted in a tissue region at or near a target nerve B,

providing at least one pulse generator to convey electrical stimulation waveforms to each of the target nerve A stimulation electrode and target nerve B stimulation electrode to stimulate the target nerve A and the target nerve B to treat sexual dysfunction,

coupling the at least one elongated target nerve A lead to one of the at least one pulse generator,

coupling the at least one elongated target nerve B lead to one of the at least one pulse generator,

implanting the at least one target nerve A stimulation electrode in a tissue region at or near a target nerve A,

implanting the at least one target nerve B stimulation electrode in a tissue region at or near a target nerve B, and

operating the pulse generator to convey electrical stimulation waveforms to each of the target nerve A stimulation electrode and target nerve B stimulation electrode to stimulate the target nerve A and the target nerve B to treat sexual dysfunction.

17. The method according to claim 16 further comprising:

diagnosing the sexual dysfunction by providing a stimulating catheter, the stimulating catheter comprising

an elongated flexible body having a proximal end and a distal end and at least one lumen extending at least a portion of the flexible body,

an inflatable balloon disposed at or near the distal end,

an electrode array disposed along the flexible body, and

an electrical lead coupled to each electrode in the electrode array and extending through the body, the electrical lead adapted for external connection to an electrical source, and

operating the stimulating catheter to convey electrical stimulation waveforms to the electrode array to stimulate at least one of the target nerve A and the target nerve B to diagnose the sexual dysfunction.

18. The method according to claim 17:

wherein the flexible body is adapted to be positioned within the urethra of a male and/or female animal or human.

19. The method according to claim 17:

wherein the flexible body is adapted to, be positioned within the rectum of a male and/or female animal or human.

20. The method according to claim 17:

wherein the flexible body is adapted to be positioned within the vagina of a female animal or human.

21. A catheter according to claim 17:

wherein the electrode array is disposed proximal to the inflatable balloon.

22. A method of using a stimulating catheter to diagnose or treat a sexual function, the method comprising:

providing a stimulating catheter, the stimulating catheter comprising

an elongated flexible body having a proximal end and a distal end and at least one lumen extending at least a portion of the body,

an inflatable balloon disposed at or near the distal end,

an electrode array disposed along the body and proximal to the inflatable balloon, and

an electrical lead coupled to each electrode in the electrode array and extending through the body, the electrical lead adapted for external connection to an electrical source,

inserting the stimulating catheter within one of the urethra and rectum and vagina of an animal or human,

inflating the balloon to secure the stimulating catheter in position, and

operating the stimulating catheter to convey electrical stimulation waveforms to the electrode array to stimulate at least one of a target nerve and muscle.

23. The method according to claim 22:

wherein the electrode array is disposed along the flexible body proximal to the inflatable balloon.

24. A neuromuscular stimulation system comprising:

at least one electrically conductive surface sized and configured for implantation on, in, or near a target nerve A affecting a sexual function,

a lead electrically coupled to the electrically conductive surface, the lead sized and configured to be positioned in subcutaneous tissue,

an implantable pulse generator sized and configured to be coupled to the lead and positioned in subcutaneous tissue in an anterior pelvic region remote from the at least one electrically conductive surface, the implantable pulse generator comprising a case having a size between about 5 mm and about 10 mm thick, between about 15 mm and about 40 mm wide, and between about 40 mm and about 60 mm long, and the implantable pulse generator comprising non-inductive wireless telemetry circuitry using VHF/UHF signals, the non-inductive wireless telemetry circuitry being functional at a distance as far as arm'"'"'s reach away from the patient, and being adapted for programming and interrogation of the implantable pulse generator.

25. A system according to claim 24:

wherein the case includes a smaller end and a larger end to facilitate placement within a subcutaneous pocket small end first.

26. A neuromuscular stimulation system comprising:

at least one electrically conductive surface sized and configured for implantation on, in, or near a target nerve B affecting a sexual function,

a lead electrically coupled to the electrically conductive surface, the lead sized and configured to be positioned in subcutaneous tissue,

an implantable pulse generator sized and configured to be coupled to the lead and positioned in subcutaneous tissue in an anterior pelvic region remote from the at least one electrically conductive surface, the implantable pulse generator comprising a case having a size between about 5 mm and about 10 mm thick, between about 15 mm and about 40 mm wide, and between about 40 mm and about 60 mm long, and the implantable pulse generator comprising non-inductive wireless telemetry circuitry using VHF/UHF signals, the non-inductive wireless telemetry circuitry being functional at a distance as far as arm'"'"'s reach away from the patient, and being adapted for programming and interrogation of the implantable pulse generator.

27. A system according to claim 26:

wherein the case includes a smaller end and a larger end to facilitate placement within a subcutaneous pocket small end first.